Biologics Working Party documents

Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2026/2027

Reference Number: EMA/CHMP/BWP/62405/2026

English (EN) (229.33 Ko - PDF)

Première publication: 30/03/2026 Dernière mise à jour: 26/05/2026

Voir

Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026

Reference Number: EMADOC-628903358-119194 Corr.1

English (EN) (144.19 Ko - PDF)

Première publication: 01/04/2025 Dernière mise à jour: 13/05/2025

Voir

Amended Biologics Working Party (BWP) Ad hoc Influenza Working Group - EU recommendations for the seasonal influenza vaccine composition for the season 2023/2024

Adopted Reference Number: EMA/CHMP/BWP/126676/2023

English (EN) (192.21 Ko - PDF)

Première publication: 03/04/2023 Dernière mise à jour: 20/04/2023

Voir

Amended Biologics Working Party (BWP) Ad hoc Influenza Working Group - EU recommendations for the seasonal influenza vaccine composition for the season 2022/2023

Reference Number: EMA/CHMP/BWP/116744/2022

English (EN) (175.47 Ko - PDF)

Première publication: 29/03/2022 Dernière mise à jour: 30/03/2022

Voir

Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2021/2022

Adopted Reference Number: EMA/CHMP/BWP/80561/2021

English (EN) (176.61 Ko - PDF)

Première publication: 30/03/2021 Dernière mise à jour: 28/06/2021

Voir

Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2020/2021

Adopted Reference Number: EMA/CHMP/BWP/134670/2020 Summary:

EU recommendations for the seasonal influenza vaccine composition for the season 2020/2021

English (EN) (205.91 Ko - PDF)

Première publication: 01/04/2020 Dernière mise à jour: 15/05/2020

Voir

Biologics Working Party (BWP) Ad hoc Influenza Working Group - Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2019/2020

Adopted Reference Number: EMA/CHMP/BWP/266098/2019

English (EN) (199.83 Ko - PDF)

Première publication: 01/04/2019 Dernière mise à jour: 20/05/2019

Voir

Biologics Working Party (BWP) ad-hoc influenza working group: Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2018/2019

Reference Number: EMA/CHMP/BWP/209019/2018

English (EN) (93.84 Ko - PDF)

Première publication: 26/03/2018 Dernière mise à jour: 30/04/2018

Voir

Biologics Working Party report on viral safety of plasma-derived and urine-derived medicinal products with respect to Zika virus

Reference Number: EMA/CHMP/BWP/596747/2016

English (EN) (115.31 Ko - PDF)

Première publication: 21/09/2016 Dernière mise à jour: 21/09/2016

Voir

Biologics Working Party (BWP) Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2017/2018

Reference Number: EMA/CHMP/BWP/216216/2017

English (EN) (83.23 Ko - PDF)

Première publication: 24/03/2017 Dernière mise à jour: 12/04/2017

Voir

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal influenza vaccine composition for the season 2016/2017

Reference Number: EMA/CHMP/BWP/165983/2016 Summary:

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal influenza vaccine composition for the season 2016/2017

English (EN) (106.94 Ko - PDF)

Première publication: 04/04/2016 Dernière mise à jour: 04/04/2016

Voir

Biologics Working Party Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal-influenza-vaccine composition for the season 2015 / 2016

Reference Number: EMA/CHMP/BWP/169555/2015

English (EN) (153.35 Ko - PDF)

Première publication: 27/03/2015 Dernière mise à jour: 27/05/2015

Voir

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal-influenza-vaccine composition for the season 2014 / 2015

Reference Number: EMA/CHMP/BWP/109993/2014

English (EN) (84.32 Ko - PDF)

Première publication: 21/03/2014 Dernière mise à jour: 21/03/2014

Voir

CHMP/Biologics Working Party report to the CMDh on pancreatin-containing products

Reference Number: EMEA/CHMP/BWP/373049/2013 Summary:

At the request of the CMDh, the Biologics Working Party (BWP) and the Committee for Medicinal Products for Human Use (CHMP) assessed the viral risk of pancreatin products and expressed their view on whether the SmPCs of these products should include a harmonised warning about their viral safety.

English (EN) (94.12 Ko - PDF)

Première publication: 04/10/2013 Dernière mise à jour: 04/10/2013

Voir

Biologics Working Party Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal-influenza-vaccine composition for the season 2013 / 2014

Adopted Reference Number: EMA/CHMP/BWP/116620/2013

English (EN) (92.22 Ko - PDF)

Première publication: 16/03/2012 Dernière mise à jour: 02/04/2013

Voir

Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal-influenza-vaccine composition for the season 2011 / 2012

Adopted Reference Number: EMA/CHMP/BWP/156215/2011

English (EN) (65.24 Ko - PDF)

Première publication: 17/03/2011 Dernière mise à jour: 17/03/2011

Voir

European Union recommendations for the seasonal-influenza-vaccine composition for the season 2010 / 2011

Adopted Reference Number: EMA/CHMP/BWP/107653/2010

English (EN) (65.29 Ko - PDF)

Première publication: 18/03/2010 Dernière mise à jour: 18/03/2010

Voir

Report of plasma master file epidemiology workshop with industry

Reference Number: EMEA/CHMP/BWP/233408/2009

English (EN) (87.41 Ko - PDF)

Première publication: 19/11/2009 Dernière mise à jour: 19/11/2009

Voir

Report: Expert workshop on Creutzfeldt-Jakob-disease risk and urine-derived medicinal products

Reference Number: EMEA/CHMP/BWP/472717/2009

English (EN) (135.72 Ko - PDF)

Première publication: 23/07/2009 Dernière mise à jour: 23/07/2009

Voir

European Union recommendation for the emergent-novel-H1N1-influenza-vaccine composition - Revised to include strain IVR-153

Adopted Reference Number: EMEA/CHMP/BWP/340831/2009/Rev 1

English (EN) (22.93 Ko - PDF)

Première publication: 10/06/2009 Dernière mise à jour: 10/06/2009

Voir

European Union recommendations for the seasonal-influenza-vaccine composition for the season 2009 / 2010

Adopted Reference Number: EMEA/CHMP/BWP/133895/2009/Rev 1

English (EN) (28.44 Ko - PDF)

Première publication: 23/04/2009 Dernière mise à jour: 23/04/2009

Voir

European Union recommendation for the seasonal-influenza-vaccine composition for the season 2008 / 2009

Adopted Reference Number: EMEA/CHMP/BWP/133836/2008

English (EN) (26.4 Ko - PDF)

Première publication: 19/03/2008 Dernière mise à jour: 19/03/2008

Voir

Biologics Working Party report to the CHMP: Beta-interferons and neutralising antibodies (in multiple sclerosis)

Reference Number: EMEA/CHMP/BWP/580136/2007

English (EN) (37.56 Ko - PDF)

Première publication: 13/02/2008 Dernière mise à jour: 13/02/2008

Voir

Report: Biologics Working Party, Process Analytical Technologies Group and industry

Reference Number: EMEA/CHMP/BWP/185370/2007

English (EN) (40.37 Ko - PDF)

Première publication: 16/07/2007 Dernière mise à jour: 16/07/2007

Voir

European Union recommendations for the influenza-vaccine composition for the season 2007 / 2008

Adopted Reference Number: EMEA/CHMP/BWP/108182/07

English (EN) (34.66 Ko - PDF)

Première publication: 19/03/2007 Dernière mise à jour: 19/03/2007

Voir

European Union recommendations for the influenza-vaccine composition for the season 2006 / 2007

Adopted Reference Number: EMEA/CHMP/BWP/123643/2006

English (EN) (38.03 Ko - PDF)

Première publication: 29/05/2006 Dernière mise à jour: 29/05/2006

Voir

European Union recommendations for the influenza-vaccine composition for the season 2005 / 2006

Adopted Reference Number: EMEA/BWP/111233/05

English (EN) (25.11 Ko - PDF)

Première publication: 30/03/2005 Dernière mise à jour: 30/03/2005

Voir

First cases of bovine spongiform encephalopathy in the United States (USA) and Canada: Risk assessment of ruminant materials originating from the USA and Canada

Adopted Reference Number: EMEA/CHMP/BWP/27/04 Legal effective date: 01/07/2004

English (EN) (173.36 Ko - PDF)

Première publication: 21/07/2004 Dernière mise à jour: 21/07/2004

Voir

European Union recommendations for the influenza-vaccine composition for the season 2004 / 2005

Adopted Reference Number: EMEA/BWP/1104/04

English (EN) (112.37 Ko - PDF)

Première publication: 21/07/2004 Dernière mise à jour: 21/07/2004

Voir

CPMP position statement on West Nile virus and plasma-derived medicinal products

Adopted Reference Number: EMEA/CPMP/BWP/3752/03/adopted Legal effective date: 25/07/2003

English (EN) (134.87 Ko - PDF)

Première publication: 25/07/2003 Dernière mise à jour: 25/07/2003

Voir

Final European Union recommendation for influenza-vaccine composition for the season 2003 / 2004

Adopted Reference Number: CPMP/BWP/6011/03

English (EN) (110.33 Ko - PDF)

Première publication: 19/03/2002 Dernière mise à jour: 19/03/2002

Voir

CPMP position statement - non-remunerated and remunerated donors: safety and suply of plasma-derived medicinal products

Adopted Reference Number: EMEA/CPMP/BWP/1818/02 Final

English (EN) (116.84 Ko - PDF)

Première publication: 30/05/2002 Dernière mise à jour: 30/05/2002

Voir

European Medicines Agency workshop on the plasma master file, 10-11 October 2001: Summary report

Reference Number: EMEA/CPMP/BWP/173/02

English (EN) (230.52 Ko - PDF)

Première publication: 18/12/2002 Dernière mise à jour: 18/12/2002

Voir

Final European Union recommendations for the influenza-vaccine composition for the season 2002 / 2003

Adopted Reference Number: CPMP/BWP/852/02

English (EN) (104.27 Ko - PDF)

Première publication: 21/03/2002 Dernière mise à jour: 21/03/2002

Voir

European Medicines Agency workshop on viral safety of plasma-derived medicinal products with particular focus on non-enveloped viruses, 13 September 2000: Summary report

Adopted Reference Number: CPMP/BWP/BPWG/4080/00

English (EN) (174.45 Ko - PDF)

Première publication: 28/03/2001 Dernière mise à jour: 28/03/2001

Voir

European Medicines Agency expert meeting on human transmissible spongiform encephalopathies and medicinal products derived from human blood and plasma, 1 December 2000: Summary report

Reference Number: EMEA/CPMP/BWP/450/01

English (EN) (176.07 Ko - PDF)

Première publication: 28/03/2001 Dernière mise à jour: 28/03/2001

Voir

Questions and answers on bovine spongiform encephalopathies (BSE) and vaccines - First version

Adopted Reference Number: EMEA/CPMP/BWP/819/01 Legal effective date: 23/04/2001

English (EN) (59.49 Ko - PDF)

Première publication: 24/04/2001 Dernière mise à jour: 24/04/2001

Voir

Thèmes

Biologicals

Related content

Thèmes

Share this page